Jasper is an applied AI company for enterprise marketing.
As AI transforms how work gets done, the systems that run your enterprise marketing organization - brand guidelines, campaign templates, review cycles - are increasingly built around the wrong worker. Jasper helps rebuild your marketing organization for this new reality, combining forward-deployed teams, a proprietary intelligence layer and purpose-built agents into one system that identifies, executes and measures the work that matters most, delivered to a standard you can trust.
Today, more than 900 enterprises, including 20% of the Fortune 500, rely on Jasper.
Initially founded in 2021 as one of the first generative AI platforms, Jasper’s investors include Insight Partners, Coatue, IVP, Foundation Capital and Bessemer Venture Partners.
BioSerenity is an international medical device and service company that develops smart healthcare solutions and provides telehealth services.
Our company is headquartered in Paris, France. We work closely with hospital doctors and researchers from across the world, and provide the medical community with the best tools for optimal patient care.
With our technical expertise and our networks from industrial and scientific partnerships, BioSerenity has provided high quality protective equipment to healthcare professionals throughout the fight against Covid-19.
We manufacture medical-grade surgical masks and FFP2-grade personal protective equipment (PPE) masks. As our DNA dictates, we had to add a touch of innovation along the way!
Compumedics, founded in 1987, is a global leader in the design & manufacture of innovative diagnostic technologies for sleep disorders, neurophysiology & cardiology.
In 1987, Compumedics established Asia Pacific’s first fully computerised sleep lab and holds 80% share of the Australian sleep-diagnostic market, and has a major & rapidly growing presence in the US, European & Asian markets for its sleep, neurological, & Doppler blood flow diagnostic monitoring devices.
In 1995, the company was selected to supply equipment to the US Sleep Heart Health Study, the world’s largest sleep study of its kind, currently exceeding 14,000 studies with 20,000 patients scheduled by 2008. With headquarters in Melbourne, Australia & offices in the US & Europe, the products are distributed in over 50 countries. Achievements include :
1998 Australian Exporter of the Year
2000 Listed on the Australian Stock Exchange
2002 Acquired US-based Neuroscan, the world's leading supplier of instruments for brain research. Neuroscan holds about 90% of the USA market for brain research products
2003 Frost & Sullivan Award for Market Expansion Strategy
2004 Acquired German-based DWL Elektronishe GmbH
2006 Frost & Sullivan Technology Leadership award for the innovative Somté
2007 Victorian Manufacturing Hall of Fame
2008 The DWL division received the top 100 German Innovation award
2009 Design award for its Grael™ PSG/EEG premium lab solution
2010 Recognised as Australia's top 100 health innovators
2011 Established direct presence in France, awarded several significant USA contracts to supply preeminent USA customers with NeuvoLTM EEG
2012 Celebrated 25 year silver jubilee anniversary ,CURRY7 and Neuvo 512 LTM EEG system released
2013 Equity issued to Beijing Bestmed, its long-term partner in China
2014 Released Upgrade to the world leading diagnostics software platform for Sleep and EEG, ProFusion
2015 Core business strengthens and returns to strong operating profitability